Seres Therapeutics, Inc. (NASDAQ:MCRB) Q4 2022 Earnings Call Transcript
Operator: Thank you for holding, and welcome everyone, to the Seres Therapeutics Fourth Quarter 2022 Conference Call. . Thank you. I will now turn the call over to Dr.
Seres Therapeutics Inc. (MCRB)
Market is closed
News
- First
- << Previous
- 11 - 20
- Next >>
Cathie Wood's Top 15 Small-Cap Stock Picks
In this article, we discuss Cathie Wood’s top 15 small-cap stock picks.
Hedge Funds Have Never Been This Bullish On Seres Therapeutics Inc (MCRB)
We at Insider Monkey have gone over 866 13F filings that hedge funds and prominent investors are required to file by the SEC.
Money Supply Is Up 26%, Inflation Coming? Cathie Wood's Bitcoin Comments and Stock Picks
In this article we talked about Cathie Wood's recent comments about money supply, inflation, interest rates, bitcoin and present Wood's top 10 small-cap stock picks.
Is MCRB A Good Stock To Buy Now?
After several tireless days we have finished crunching the numbers from nearly 817 13F filings issued by the elite hedge funds and other investment firms that we track at Insider Monkey, which disclosed...
Hedge Funds Have Never Been Less Bullish On Seres Therapeutics Inc (MCRB)
We at Insider Monkey have gone over 821 13F filings that hedge funds and prominent investors are required to file by the SEC The 13F filings show the funds' and investors' portfolio positions as of March...
Hedge Funds Are Dumping Seres Therapeutics Inc (MCRB)
Is Seres Therapeutics Inc (NASDAQ:MCRB) a good investment right now? We check hedge fund and billionaire investor sentiment before delving into hours of research.
Seres Therapeutics Inc (MCRB) Announces New "Poop Pill" Phase 2 Study
Plans to start a new Phase II study of SER-109, branded ECOSPOR III, have been announced by Seres Therapeutics Inc (NASDAQ:MCRB).
Is Seres Therapeutics Inc (MCRB) A Good Stock To Buy?
The worries about the election and the ongoing uncertainty about the path of interest-rate increases have been keeping investors on the sidelines.
What’s Next For Seres Therapeutics Inc (MCRB)?
Seres Therapeutics Inc (NASDAQ:MCRB) just put out interim data from its lead trial, and the data doesn’t look good.
- First
- << Previous
- 11 - 20
- Next >>
Billionaire Hedge Funds
